American Resources Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by American Resources Corporation (Florida) on April 5, 2021, covering events occurring on March 31, 2021. The filing details a strategic partnership and equity transaction with Novusterra Inc. focused on graphene technologies.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for American Resources Corporation. The financial impact is defined by the terms of a new agreement rather than historical performance data.
Material Changes and Agreements
On March 31, 2021, the Company entered into a sublicense and development agreement and a stock acquisition agreement with Novusterra Inc. Key terms include:
- Revenue Share: American Resources will receive 50% of the positive operating income generated by Novusterra from the manufacturing and sales of Graphene Technologies.
- Equity Stake: The Company received 10,000,000 shares of Novusterra Class B Common Stock and 5,700,000 shares of Novusterra Class A Common Stock.
- Ownership and Control: These shares collectively represent 50.0% ownership and 87.5% voting rights of Novusterra as of the transaction date.
- Stock Conversion: Subsequent to the agreement, American Resources converted all 10,000,000 Class B shares into Class A Common Stock, and Novusterra agreed to cancel the Class B Common Stock.
Guidance, Risks, and Unusual Items
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the standard securities law disclosures. The transaction relies on exemptions from registration under Section 4(a)(2) of the Securities Act of 1933, as the shares issued were not registered.
Investor Verification Checklist
- Verify the current valuation and trading status of Novusterra Inc. to assess the value of the 50% equity stake.
- Confirm the commercialization timeline and revenue projections for the Graphene Technologies.
- Review the full text of the Graphene Development Agreement (Exhibit 99.1) and Stock Acquisition Agreement (Exhibit 99.2) for specific covenants and termination clauses.
- Check for any subsequent filings regarding the financial performance of Novusterra to validate the "positive operating income" revenue stream.